CanProVar: a Human Cancer Proteome Variation Database

Overview

Journal Hum Mutat

Specialty Genetics

Date 2010 Jan 7

PMID 20052754

Citations 37

Authors

Jing Li

Dexter T Duncan

Bing Zhang

Affiliations

Soon will be listed here.

Abstract

Identification and annotation of mutated genes or proteins involved in oncogenesis and tumor progression are crucial for both cancer biology and clinical applications. We have developed a human Cancer Proteome Variation Database (CanProVar) by integrating information on protein sequence variations from various public resources, with a focus on cancer-related variations (crVAR). We have also built a user-friendly interface for querying the database. The current version of CanProVar comprises 8,570 crVARs in 2,921 proteins derived from existing genome variation databases and recently published large-scale cancer genome resequencing studies. It also includes 41,541 non-cancer specific variations (ncsVARs) in 30,322 proteins derived from the dbSNP database. CanProVar provides quick access to known crVARs in protein sequences along with related cancer samples, relevant publications, data sources, and functional information such as Gene Ontology (GO) annotations for the proteins, protein domains in which the variation occurs, and protein interaction partners with crVARs. CanProVar also helps reveal functional characteristics of crVARs and proteins bearing these variations. Our analysis showed that crVARs were enriched in certain protein domains. We also showed that proteins bearing crVARs were more likely to interact with each other in the protein interaction network. CanProVar can be accessed from http://bioinfo.vanderbilt.edu/canprovar.

Citing Articles

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma.

Kuras M, Betancourt L, Hong R, Szadai L, Rodriguez J, Horvatovich P Cancers (Basel). 2025; 17(5).

PMID: 40075679 PMC: 11899103. DOI: 10.3390/cancers17050832.

Integration of proteomics profiling data to facilitate discovery of cancer neoantigens: a survey.

Luo S, Peng H, Shi Y, Cai J, Zhang S, Shao N Brief Bioinform. 2025; 26(2).

PMID: 40052441 PMC: 11886573. DOI: 10.1093/bib/bbaf087.

Deciphering Cancer Complexity: Integrative Proteogenomics and Proteomics Approaches for Biomarker Discovery.

Rao R, Gulfishan M, Kim M, Kashyap M Methods Mol Biol. 2024; 2859:211-237.

PMID: 39436604 DOI: 10.1007/978-1-0716-4152-1_12.

Cancer pharmacoinformatics: Databases and analytical tools.

Kamble P, Nagar P, Bhakhar K, Garg P, Sobhia M, Naidu S Funct Integr Genomics. 2024; 24(5):166.

PMID: 39294509 DOI: 10.1007/s10142-024-01445-5.

Genome interpretation using in silico predictors of variant impact.

Katsonis P, Wilhelm K, Williams A, Lichtarge O Hum Genet. 2022; 141(10):1549-1577.

PMID: 35488922 PMC: 9055222. DOI: 10.1007/s00439-022-02457-6.

References

von Eschenbach A, Buetow K . Cancer informatics vision: caBIG. Cancer Inform. 2009; 2:22-4. PMC: 2675495. View

Yokoyama A, Cleary M . Menin critically links MLL proteins with LEDGF on cancer-associated target genes. Cancer Cell. 2008; 14(1):36-46. PMC: 2692591. DOI: 10.1016/j.ccr.2008.05.003. View

Rhee H, Lee J . MedRefSNP: a database of medically investigated SNPs. Hum Mutat. 2008; 30(3):E460-6. DOI: 10.1002/humu.20914. View

Chatr-Aryamontri A, Ceol A, Palazzi L, Nardelli G, Schneider M, Castagnoli L . MINT: the Molecular INTeraction database. Nucleic Acids Res. 2006; 35(Database issue):D572-4. PMC: 1751541. DOI: 10.1093/nar/gkl950. View

Feng L, Ou Z, Wu F, Shen Z, Shao Z . Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival. Clin Cancer Res. 2009; 15(9):2962-70. DOI: 10.1158/1078-0432.CCR-08-2495. View

Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A . The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer. 2004; 91(2):355-8. PMC: 2409828. DOI: 10.1038/sj.bjc.6601894. View

Fong J, Geer L, Panchenko A, Bryant S . Modeling the evolution of protein domain architectures using maximum parsimony. J Mol Biol. 2006; 366(1):307-15. PMC: 1858635. DOI: 10.1016/j.jmb.2006.11.017. View

Lindstrom M, Jin A, Deisenroth C, White Wolf G, Zhang Y . Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation. Mol Cell Biol. 2006; 27(3):1056-68. PMC: 1800693. DOI: 10.1128/MCB.01307-06. View

Chou T, Chiu C, Li L, Hsiao C, Tzen C, Chang K . Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer. Clin Cancer Res. 2005; 11(10):3750-7. DOI: 10.1158/1078-0432.CCR-04-1981. View

10.

Uzun A, Leslin C, Abyzov A, Ilyin V . Structure SNP (StSNP): a web server for mapping and modeling nsSNPs on protein structures with linkage to metabolic pathways. Nucleic Acids Res. 2007; 35(Web Server issue):W384-92. PMC: 1933130. DOI: 10.1093/nar/gkm232. View

11.

Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G . Patterns of somatic mutation in human cancer genomes. Nature. 2007; 446(7132):153-8. PMC: 2712719. DOI: 10.1038/nature05610. View

12.

Schandorff S, Olsen J, Bunkenborg J, Blagoev B, Zhang Y, Andersen J . A mass spectrometry-friendly database for cSNP identification. Nat Methods. 2007; 4(6):465-6. DOI: 10.1038/nmeth0607-465. View

13.

ODonovan C, Apweiler R, Bairoch A . The human proteomics initiative (HPI). Trends Biotechnol. 2001; 19(5):178-81. DOI: 10.1016/s0167-7799(01)01598-0. View

14.

Weinstein I . Cancer. Addiction to oncogenes--the Achilles heal of cancer. Science. 2002; 297(5578):63-4. DOI: 10.1126/science.1073096. View

15.

Pincus D, Letunic I, Bork P, Lim W . Evolution of the phospho-tyrosine signaling machinery in premetazoan lineages. Proc Natl Acad Sci U S A. 2008; 105(28):9680-4. PMC: 2443182. DOI: 10.1073/pnas.0803161105. View

16.

Sunyaev S, Ramensky V, Koch I, Lathe 3rd W, Kondrashov A, Bork P . Prediction of deleterious human alleles. Hum Mol Genet. 2001; 10(6):591-7. DOI: 10.1093/hmg/10.6.591. View

17.

Futreal P, Coin L, Marshall M, Down T, Hubbard T, Wooster R . A census of human cancer genes. Nat Rev Cancer. 2004; 4(3):177-83. PMC: 2665285. DOI: 10.1038/nrc1299. View

18.

Jegga A, Gowrisankar S, Chen J, Aronow B . PolyDoms: a whole genome database for the identification of non-synonymous coding SNPs with the potential to impact disease. Nucleic Acids Res. 2006; 35(Database issue):D700-6. PMC: 1669724. DOI: 10.1093/nar/gkl826. View

19.

Rikova K, Guo A, Zeng Q, Possemato A, Yu J, Haack H . Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell. 2007; 131(6):1190-203. DOI: 10.1016/j.cell.2007.11.025. View

20.

Dantzer J, Moad C, Heiland R, Mooney S . MutDB services: interactive structural analysis of mutation data. Nucleic Acids Res. 2005; 33(Web Server issue):W311-4. PMC: 1160165. DOI: 10.1093/nar/gki404. View